TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

QUANTON

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

QUANTON

ST13

US500000079158317

Classe

5, 9, 42

Pedido

79158317

Registro

4890835

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

56

Atualização mais recente

07/05/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 9, 42

Data de depósito

29/09/2014

Data de registro

26/01/2016

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

06/05/2026

Última transação

07/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

706

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

09

Localização do titular

Bensheim, DE

Examinador

CUCCIAS, MATTHEW JAMES

Localização atual

Historical data usage

Titulares e representantes

Titulares

Immundiagnostik AG
Immundiagnostik AG

Representantes

GABRIELLE S. ROTH SUGHRUE MION, PLLC

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

[ Diagnostic reagents for medical purposes; Diagnostic chemical reagents for medical purposes; ] Diagnostic chemical preparations for medical purposes, namely, for diagnosing and monitoring gastroenterological diseases, inflammatory bowel syndrome, inflammatory bowel disease, colitis ulcerosa, Morbus Crohn and for monitoring the effects of TNF-blocker on these conditions; [ diagnostic preparations for medical or veterinary purposes; ] diagnostic preparations for medical purposes [ ; diagnostic preparations for pharmaceutical purposes; reagents for in vitro laboratory tests for medical purposes; reagents for in vitro laboratory use for veterinary purposes ]

Classe 9

[ Computer software for creating searchable databases containing information and data; ] computer software in the nature of a mobile application for use with immunochromatographic devices that test for a specific protein or antigen in a sample of body fluid or stool, and for which the software converts the analytical result to information that can be read by patients and physicians, using mobile phones or smart phones, once calibration data is downloaded from a global computer network; production lot encoded immunochromatographic devices that test for the presence of a specific protein or antigen in a sample of body fluid or stool which is converted to an analytical result that can be read by patients and physicians, using mobile phones or smart phones, once calibration data is downloaded from a global computer network; patient encoded immunochromatographic devices that determine the level of an antigen in a test sample, the results of which can be transmitted through use of a mobile app to a medical advisor, physician or doctor using a mobile phone or smart phone; machine readable immunochromatographic devices, namely, handheld immunochromatographic devices which produce test results that use a mobile app to scan and evaluate the results

Classe 42

[ Biological research, clinical and medical research; ] design and programming of computer software in the medical field [ ; services of a chemical and biological laboratory; analysis of human sera for medical research; medical and pharmaceutical research services ]

Publicações

Histórico de despachos e eventos da marca no USPTO.

56 publicações encontradas

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

06/05/2026

71AG

REGISTERED-SEC.71 ACCEPTED

06/05/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/05/2026

ES71

TEAS SECTION 71 RECEIVED

13/01/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

21/11/2025

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

26/01/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

17/10/2024

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

25/09/2023

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

21/08/2023

INPC

INVALIDATION PROCESSED

21/08/2023

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

25/07/2023

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

25/11/2022

71AG

REGISTERED-SEC.71 ACCEPTED

25/11/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

22/11/2022

ES71

TEAS SECTION 71 RECEIVED

08/06/2022

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

26/01/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

15/07/2016

FICS

FINAL DISPOSITION NOTICE SENT TO IB

27/04/2016

FIMP

FINAL DISPOSITION PROCESSED

27/04/2016

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

26/04/2016

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/03/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

26/01/2016

GPNX

NOTIFICATION PROCESSED BY IB

20/11/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/11/2015

PUBO

PUBLISHED FOR OPPOSITION

10/11/2015

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/11/2015

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/11/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

21/10/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/10/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

23/09/2015

XAEC

EXAMINER'S AMENDMENT ENTERED

14/09/2015

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

14/09/2015

GNEA

EXAMINERS AMENDMENT E-MAILED

14/09/2015

CNEA

EXAMINERS AMENDMENT -WRITTEN

14/09/2015

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

09/09/2015

GNFR

FINAL REFUSAL E-MAILED

09/09/2015

CNFR

FINAL REFUSAL WRITTEN

09/09/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

17/08/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

17/08/2015

ALIE

ASSIGNED TO LIE

07/08/2015

NREP

NEW REPRESENTATIVE AT IB RECEIVED

31/07/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

27/07/2015

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/04/2015

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/04/2015

RFNP

REFUSAL PROCESSED BY IB

20/02/2015

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

30/01/2015

RFRR

REFUSAL PROCESSED BY MPU

30/01/2015

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

30/01/2015

CNRT

NON-FINAL ACTION WRITTEN

29/01/2015

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

23/01/2015

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

23/01/2015

CNRT

NON-FINAL ACTION WRITTEN

22/01/2015

DOCK

ASSIGNED TO EXAMINER

19/01/2015

MAFR

APPLICATION FILING RECEIPT MAILED

13/01/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/01/2015

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/01/2015

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace QUANTON ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.